Themis Bioscience's Seed Round

Themis Bioscience raised a round of funding on September 01, 2009. Investors include Austria Wirtschaftsservice.

Themis Bioscience develops prophylactic vaccines with a focus on emerging tropical infectious diseases and has initial vaccine candidates currently in development for chikungunya and dengue fever. The…

Articles about Themis Bioscience's Seed Round: